<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04900142</url>
  </required_header>
  <id_info>
    <org_study_id>1152/2019/DISP/AOUMO</org_study_id>
    <nct_id>NCT04900142</nct_id>
  </id_info>
  <brief_title>Micropulsed Laser Trabeculoplasty Using Different Parameters</brief_title>
  <official_title>Micropulsed Laser Trabeculoplasty: a Randomized Double Blinded Clinical Trial Using Different Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Modena and Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Modena and Reggio Emilia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized, double blinded, clinical trial compares two different parameters setting of&#xD;
      micropulsed laser trabeculoplasty for open angle glaucoma. Group one is treated with 1500 mW&#xD;
      of Power, Group two with 1000 mW. The other settings (300 micron of diameter, 300 ms of&#xD;
      duration, 15% duty cycle) are the same for both groups, and the laser is applied for 360Â°.&#xD;
&#xD;
      The main outcome is to evaluate the IOP (IntraOcular Pressure) lowering effects of both&#xD;
      treatments and the safety on the corneal endothelium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, double blinded, clinical trial. Eligibility criteria are: primary&#xD;
      open angle glaucoma, pigmentary glaucoma and pseudoexfoliation glaucoma.&#xD;
&#xD;
      Exclusion criteria are: secondary glaucoma, previous glaucoma surgery (not including cataract&#xD;
      surgery as a glaucoma surgery), uncooperative patients, corneal endothelial diseases (such as&#xD;
      Fuchs dystrophy or cornea guttata) and severely decompensated glaucoma.&#xD;
&#xD;
      Both eyes of the patient are treated: each eye is allocated in a group using the closed&#xD;
      envelopes method. Both the patient and the surgeon who performs the post laser examinations&#xD;
      are not aware of the group allocation.&#xD;
&#xD;
      The exams required before the trabeculoplasty are: best corrected visual acuity, IOP&#xD;
      measurement, specular microscopy with corneal central thickness.&#xD;
&#xD;
      The IOP is measured an hour after MLT (micropulsed laser trabeculoplasty), then on day one,&#xD;
      at one month, at three months and six months. Best corrected visual acuity and specular&#xD;
      microscopy are repeated at three months.&#xD;
&#xD;
      Expected outcomes: to compare the IOP lowering effects between group one and two and to&#xD;
      assess the safety of the procedure on the corneal endothelium.&#xD;
&#xD;
      Secondary outcomes: decrease the number of glaucoma medications applied by the patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Anticipated">June 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IOP lowering effect</measure>
    <time_frame>Up to six months</time_frame>
    <description>Using a tonometer, we will evaluate the difference in intraocular pressure between baseline and after the treatment. The values will be expressed in mmHg.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glaucoma, Open-Angle</condition>
  <arm_group>
    <arm_group_label>1500 mW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1500 mW of Power</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1000 mW</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment, 1000 mW</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Micropulsed laser trabeculoplasty</intervention_name>
    <description>Trabeculoplasty</description>
    <arm_group_label>1000 mW</arm_group_label>
    <arm_group_label>1500 mW</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary open angle glaucoma&#xD;
&#xD;
          -  Pigmentary glaucoma&#xD;
&#xD;
          -  Pseudoexfoliative glaucoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Secondary glaucoma&#xD;
&#xD;
          -  Previous glaucoma surgery&#xD;
&#xD;
          -  Severely decompensated glaucoma&#xD;
&#xD;
          -  Corneal endothelial disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mastropasqua Rodolfo, MD, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Policlinico di Modena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matteo Gironi, MD</last_name>
    <phone>0594225087</phone>
    <email>matteo.gironi@hotmail.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Verdina, MD, PhD</last_name>
      <phone>+390594225047</phone>
      <email>tommaso.verdina@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bruno Battaglia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Gironi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tommaso Verdina, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cavallini Gian Maria, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mastropasqua Rodolfo, MD, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Gironi</last_name>
      <phone>0594225087</phone>
      <email>matteo.gironi@hotmail.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2021</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Modena and Reggio Emilia</investigator_affiliation>
    <investigator_full_name>Gian Maria Cavallini</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

